RecruitingPhase 3NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sponsor: Sanofi
Richmond, VA · +20 more sites
7 recruiting sickle cell disease studies with a site in Richmond, VA.
Sponsor: Sanofi
Richmond, VA · +20 more sites
Sponsor: University of Pittsburgh
Richmond, VA · +13 more sites
Sponsor: CSL Behring
Richmond, VA · +19 more sites
Sponsor: Novo Nordisk A/S
Richmond, VA · +38 more sites
Sponsor: Novo Nordisk A/S
Fairfax, VA · Norfolk, VA · Richmond, VA · +47 more sites
Sponsor: Bristol-Myers Squibb
Fairfax, VA · Richmond, VA · +17 more sites
Sponsor: CSL Behring
Richmond, VA · +8 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.